CEROGENIX
CEROGENIX
Industry:
Health Care Health Diagnostics Pharmaceutical
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
Total Funding:
370 K GBP
Similar Organizations
Boehringer Mannheim
Boehringer Mannheim is a Germany-based maker of drugs and diagnostic products.
Detectan
Detectan is a medical innovation company for diagnostics.
GryNumber Health
GryNumber Health is a commercial-stage pharma and diagnostics company.
Transition Bio
Transition Bio provides condensate technology for drug discovery and diagnostics.
Investors List
IP Group
IP Group investment in Seed Round - Cerogenix
More informations about "Cerogenix"
Cetogenix - Tackling climate change at a global scale
Cetogenix is a New Zealand-based, global-focused climate tech company unlocking the hidden potential of organic waste streams to deliver renewable carbon resources.See details»
OnSource Corporation Changes Name to Ceragenix
DENVER, June 27, 2005 (PRIMEZONE) -- OnSource Corporation ("OnSource") has changed its name to Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP). The change in name follows the โฆSee details»
Ceragenix Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
May 7, 2025 Explore Ceragenix Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 1 literature, Drug:Ceragenin.See details»
OnSource Corporation Changes Name to Ceragenix Pharmaceuticals
Jul 7, 2005 OnSource Corporation has changed its name to Ceragenix Pharmaceuticals, Inc. The change in name follows the merger of OnSource with Osmotics Pharma, Inc. on May 11, โฆSee details»
Ceragenix Pharmaceuticals, Inc. · 1444 Wazee St, Suite 210
Ceragenix Pharmaceuticals, Inc. (Entity #20051189907) is a FPC in Denver, Colorado registered with the Colorado Department of State (CDOS). The entity was formed on May 9, 2005 in the โฆSee details»
Organization | Ceragenix Pharmaceuticals
Ceragenix Pharmaceuticals Report issue For profit Phase 4 Founded: Denver CO United States (2002) Status: Defunct (2017)See details»
Cerogenix - VentureRadar
Cerogenix is developing novel therapeutics for neurological diseases such as Alzheimer's and Parkinson's disease. Near term developments will focus on a diagnostic tool for the early โฆSee details»
CEROGENIX LIMITED insolvency - Find and update company โฆ
Mar 2, 2009 CEROGENIX LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, โฆSee details»
www.ceragenix.com
Www.ceragenix.comSee details»
OrganOx - OrganOx
And improve outcomes OrganOx metra is transforming liver transplantation, enabling functional assessment of donor organs prior to transplantation, โฆSee details»
Cerogenix · GitHub
Cerogenix has one repository available. Follow their code on GitHub.See details»
CERAGENIX - Ceragenix Corporation Trademark Registration
Trademark registration by Ceragenix Corporation for the trademark CERAGENIX.See details»
Similar companies to Cerogenix | VentureRadar
Companies like Cerogenix. Similar companies and competitors including the VentureRadar Innovation and Growth scores, Company Information, Location and more.See details»
OnSource changes name to Ceragenix Pharmaceuticals.
Aug 1, 2005 OnSource Corporation has changed its name to Ceragenix Pharmaceuticals, Inc. The change in name follows the merger of OnSource with Osmotics Pharma, Inc. on May 11, โฆSee details»
Ceragenix and Pediapharm Enter Into Distribution and Supply โฆ
Feb 25, 2009 Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram® Pediapharm to Register, Market and Sell in Canada. Denver, CO and Montreal, โฆSee details»
Cetogenix
Cetogenix is a clean technology company focused on developing sustainable solutions to tackle climate change at a global scale. Our first technology targets the 1.5 billion tonnes of organic โฆSee details»
Our History โ Theragenics
AgX100® receives FDA 510 (k) clearance. Juniper Investment Company acquires Theragenics and takes the organization private. Our company continues to build on its foundation as a โฆSee details»
Ceragenix Enters into Agreement to License CSA-54 and other โฆ
Mar 25, 2008 We believe that CSA-54 and other Ceragenin compounds may play a vital role in this effort and we plan to use the resources of a leading contract research organization with โฆSee details»
์ธ๋ผ์ ๋์ค ์ ์ฝ - ์๋ค์ํค
Ceragenix Pharmacuticals, Inc.๋ ์ฝ๋ก๋ผ๋์ฃผ ๋ด๋ฒ์ ๋ณธ์ฌ๋ฅผ ๋ ๋ฐ์ด์ค ์ ์ฝ ํ์ฌ๋ก์, ์๋ก์ด ์ข ๋ฅ์ ๊ด๋ฒ์ํ ํญ๊ฐ์ผ์ ์ธ ํผ๋ถ ๋ณดํธ ๊ธฐ์ (BRT)๊ณผ Cerageninis๋ฅผ ๊ธฐ๋ฐ์ผ๋ก ํ ์ฒ๋ฐฉ ์๋ฒ์ โฆSee details»
About - Xiogenix
In 2022, we embarked on an exciting journey by entering the Cell & Gene therapy market. By harnessing our expertise in aseptic processing design, we introduced groundbreaking โฆSee details»